Norges Bank Fate Therapeutics Inc Transaction History

Norges Bank

  • $716 Trillion
  • Q3 2024

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024
BUY
$1.65 - $3.94 $70,408 - $168,127
42,672 New
42,672 $159,000
Q3 2023

Nov 13, 2024
BUY
$2.02 - $5.04 $86,197 - $215,066
42,672 New
42,672 $90,000
Q3 2023

Nov 13, 2023
SELL
$2.02 - $5.04 $1.42 Million - $3.55 Million
-705,014 Closed
0 $0
Q2 2023

Aug 14, 2024
BUY
$4.76 - $6.59 $1.37 Million - $1.9 Million
287,672 New
287,672 $1.37 Million
Q2 2023

Aug 14, 2023
SELL
$4.76 - $6.59 $3.36 Million - $4.65 Million
-705,014 Closed
0 $0
Q1 2023

May 15, 2024
BUY
$4.24 - $11.12 $4.05 Million - $10.6 Million
954,539 New
954,539 $5.44 Million
Q4 2022

Feb 14, 2023
BUY
$9.86 - $23.83 $7.93 Million - $19.2 Million
804,742 New
804,742 $8.12 Million
Q3 2022

Nov 13, 2023
BUY
$21.04 - $36.06 $14.8 Million - $25.4 Million
705,014 New
705,014 $15.8 Million
Q2 2022

Aug 14, 2023
BUY
$17.78 - $42.39 $12.5 Million - $29.9 Million
705,014 New
705,014 $17.5 Million
Q1 2022

May 12, 2023
SELL
$29.67 - $60.28 $7.3 Million - $14.8 Million
-246,114 Reduced 30.58%
558,628 $21.7 Million
Q1 2022

May 09, 2022
SELL
$29.67 - $60.28 $23.4 Million - $47.6 Million
-789,454 Closed
0 $0
Q4 2021

Mar 09, 2022
BUY
$47.84 - $64.34 $37.8 Million - $50.8 Million
789,454 New
789,454 $46.2 Million
Q3 2021

Nov 14, 2022
BUY
$59.27 - $95.73 $45.3 Million - $73.1 Million
763,829 New
763,829 $45.3 Million
Q3 2021

Nov 05, 2021
SELL
$59.27 - $95.73 $43.1 Million - $69.6 Million
-727,557 Closed
0 $0
Q2 2021

Aug 15, 2022
BUY
$67.25 - $92.52 $48.9 Million - $67.3 Million
727,557 New
727,557 $63.1 Million
Q2 2021

Aug 10, 2021
SELL
$67.25 - $92.52 $55.2 Million - $75.9 Million
-820,405 Closed
0 $0
Q1 2021

May 09, 2022
BUY
$72.16 - $117.4 $59.2 Million - $96.3 Million
820,405 New
820,405 $67.6 Million
Q1 2021

May 07, 2021
SELL
$72.16 - $117.4 $60.7 Million - $98.7 Million
-840,713 Closed
0 $0
Q4 2020

Mar 02, 2021
BUY
$38.09 - $100.95 $32 Million - $84.9 Million
840,713 New
840,713 $76.4 Million
Q4 2020

Feb 10, 2021
SELL
$38.09 - $100.95 $33.3 Million - $88.2 Million
-873,914 Closed
0 $0
Q3 2020

Nov 12, 2021
BUY
$30.41 - $40.5 $26.6 Million - $35.4 Million
873,914 New
873,914 $34.9 Million
Q3 2020

Nov 10, 2020
SELL
$30.41 - $40.5 $2.55 Million - $3.4 Million
-83,900 Closed
0 $0
Q2 2020

Aug 13, 2021
BUY
$20.21 - $35.23 $1.7 Million - $2.96 Million
83,900 New
83,900 $2.88 Million

Others Institutions Holding FATE

# of Institutions
175
Shares Held
115M
Call Options Held
53.7K
Put Options Held
9K
View Full List

About FATE THERAPEUTICS INC

FATE Quotes by TradingView
  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $143M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email